Co action of CFTR and AQP1 increases permeability of peritoneal epithelial cells on estrogen-induced ovarian hyper stimulation syndrome

BMC Cell Biology

Qin-Fu Han³  Ling Li¹  Yong-Chao Lu²  Pei-Yin Jin³ 

[1] Department of Cardiovascular Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Department of Reproductive Technology, Henan Provincial institute for Polulation and Family Planning Research, Zhengzhou, Henan, 450002, China;Department of Cardiovascular Medicine, The People’s Hospital of Anyang, Anyang, Henan, 455000, China

关键词: Ovarian hyper stimulation syndrome;    Estrogen;    AQP1;    CFTR;   

Others  :  856765
DOI  :  10.1186/1471-2121-13-23

 received in 2011-12-25, accepted in 2012-08-22,  发布年份 2012

【 摘 要 】

Background

Ovarian hyper stimulation syndrome (OHSS) is an iatrogenic complication associated with fertility drugs. It is characterized by increased vascular permeability and substantial fluid shift with accumulation in the body cavity. The pathogenesis of OHSS remains obscure, and no definitive treatments are currently available.

Results

Using western blot and short-circuit current (Isc) techniques, we investigate the potential coactions of analysis in cystic fibrosis transmembrane conductance regulator (CFTR) and aquaporin 1 (AQP1) on the hyper permeability of body cavity peritoneal epithelial cells in the pathogenesis of OHSS. The rats develop OHSS symptoms, with the up regulation of both CFTR and AQP1 expression and enhanced CFTR channel activity in peritoneal epithelial cells, can also be mimicked by administration of estrogen, alone in ovariectomized rats. Administration of progesterone suppresses CFTR activity, OHSS symptoms as well as CFTR and AQP1 expression. Besides, AQP1 inhibitor, HgCl₂, can suppress CFTR channel activity. Therefore, antisera against CFTR or AQP1 to OHSS animals may result in alleviation of the symptom.

Conclusion

This study confirms the coactions of CFTR and AQP1 play a critical role in the development and progression of increased peritoneal epithelial permeability in severe OHSS. These findings may provide grounds for ameliorating assisted reproduction treatment strategy to reduce the risk of OHSS in in vitro fertilization (IVF).

【 授权许可】

   
2012 Jin et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Navot D, Bergh PA, Laufer N: Ovarian hyper stimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992, 58:249-261.
• [2]Balasch J, Fabregues F, Arroyo V: Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyper stimulation syndrome. Hum Reprod 1998, 13:271-273.
• [3]Navot D, Bergh PA, Laufer N: The ovarian hyper stimulation syndrome. In Reproductive endocrinology, surgery and technology. Edited by Adashi EY, Rock JA, Rosenwaks Z. Lippincott-Raven, Philadelphia; 1995:2215-2232.
• [4]Pellicer A, Albert C, Mercader A, Bonilla-Musoles F: Remohı´ J, Simo´n C: The pathogenesis of ovarian hyper stimulation syndrome: in vivo studies investigating the role of interleukin (IL)-1β, IL-6 and vascular endothelial growth factor (VEFG). Fertil Steril 1999, 71:482-489.
• [5]Go´mez R, Simo´n C, Remohı´ J, Pellicer A: Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology 2002, 143:4339-4348.
• [6]Go´mez R, Simo´n C, Remohı´ J, Pellicer A: Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003, 68:2164-2171.
• [7]Garcı´A-Velasco JA, Zun˜ iga A, Pacheco A, Go´mez R, Simo´n C, Remohı´ J, Pellicer A: Coasting acts through downregulation of VEGF gene expression and protein secretion. Hum Reprod 2004, 19:1530-1538.
• [8]Verkman AS: Aquaporins in endothelia. Kidney Int 2006, 69:1120-1123.
• [9]Gabriel SE, Brigman KN, Koller BH, Boucher RC, Stutts MJ: Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 1994, 266:107-109.
• [10]Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989, 245:1073-1080.
• [11]Quinton PM: Physiological basis of cystic fibrosis: a historical perspective. Physiol Rev 1999, 79:S3-S22.
• [12]Ajonuma LC, Tsang LL, Zhang GH, Wong HY, Lau MC, Ho LS, Rowlands DK, Zhou CX, Ng CP, Chen J, Xu PH, Zhu JX, Chung YW, Chan HC: Estrogen-induced abnormally high cystic fibrosis transmembrane conductance regulator expression results in ovarian hyper stimulation syndrome. Mol Endocrinol 2005, 19:3038-3044.
• [13]Trezise AE, Buchwald M: In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 1991, 353:434-437.
• [14]Tizzano EF, Silver MM, Chitayat D, Benichou JC, Buchwald M: Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am J Pathol 1994, 44:906-914.
• [15]Rochwerger L, Buchwald M: Stimulation of the cystic fibrosis transmembrane conductance regulator expression by estrogen in vivo. Endocrinology 1993, 133:921-930.
• [16]Rochwerger L, Dho S, Parker L, Foskett JK, Buchwald M: Estrogen-dependent expression of the cystic fibrosis transmembrane conductance regulator gene in a novel uterine epithelial cell line. J Cell Sci 1994, 107:2439-2448.
• [17]Mularoni A, Beck L, Sadir R, Adessi GL, Nicollier M: Down-regulation by progesterone of CFTR expression in endometrial epithelial cells: a study by competitive RT-PCR. Biochem Biophys Res Commun 1995, 217:1105-1111.
• [18]Chan LN, Chung YW, Leung PS, Liu CQ, Chan HC: Activation of an adenosine 3,5-cyclic monophosphatedependent Cl- conductance in response to neurohormonal stimuli in mouse endometrial epithelial cells: the role of cystic fibrosis transmembrane conductance regulator. Biol Reprod 1999, 60:374-380.
• [19]Chan LN, Tsang LL, Rowlands DK, Rochelle LG, Boucher RC, Liu CQ, Chan HC: Distribution of epithelial sodium channels (ENaC) subunits and cystic fibrosis transmembrane conductance regulator (CFTR) in murine reproductive tract. J Membr Biol 2002, 185:165-176.
• [20]Nielsen S, Smith BL, Christensen EI, Agre P: Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci 1993, 90:7275-7279.
• [21]Hasegawa H, Lian SC, Finkbeiner WE, Verkman AS: Extrarenal tissue distribution of CHIP28 water channels by in situ hybridization and antibody staining. Am J Physiol 1994, 266:C893-C903.
• [22]Yang BX, Folkesson HG, Yang J, Matthay MA, Ma TH, Verkman AS: Reduced osmotic water permeability of the peritoneal barrier in aquaporin-1 knockout mice. Am J Physiol Cell Physiol 1999, 276:76-81.
• [23]Richard C, Gao J, Brown N, Reese J: Aquaporin water channel genes are differentially expressed and regulated by ovarian steroids during the periimplantation period in the mouse. Endocrinology 2003, 144:1533-1541.
• [24]Lindsay LA, Murphy CR: Redistribution of aquaporins 1 and 5 in the rat uterus is dependent on progesterone: a study with light and electron microscopy. Reproduction 2006, 131:369-378.
• [25]Manau D, Balasch J, Arroyo V, Jimenez W, Fabregues F, Casamitjana R, Creus M, Vanrell JA: Circulatory dysfunction in asymptomatic in vitro fertilization patients: relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab 1998, 83:1489-1493.
• [26]Raziel A, Friedler S, Schachter M, Strassburger D, Mordechai E, Ron-El R: Increased early pregnancy loss in IVF patients with severe ovarian hyper stimulation syndrome. Hum Reprod 2002, 17:107-110.
• [27]Delvigne A, Rozenberg S: Epidemiology and prevention of ovarian hyper stimulation syndrome (OHSS): a review. Hum Reprod Update 2002, 8:559-577.
• [28]Costabile L, Unfer V, Manna C, Gerli S, Rossetti D, Di Renzo GC: Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyper stimulation syndrome. Gynecol Obstet Invest 2000, 50:182-185.
• [29]Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS: Thiazolidinone CFTR inhibitor identified by high-throughput blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002, 110:1651-1658.
• [30]Penzias AS: Luteal phase support. Fertil Steril 2002, 77:318-323.
• [31]Schreiber R, Nitschke R, Greger R, Kunzelmann K: The cystic fibrosis transmembrane conductance regulator activates aquaporin 3 in airway epithelial cells. J Biol Chem 1999, 274:11811-11816.
• [32]Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC: CFTR as a cAMP-dependent regulator of sodium channels. Science 1995, 269:847-850.
• [33]Ohba T, Ujioka T, Ishikawa K, Tanaka N, Okamura H: Ovarian hyper stimulation syndrome-model rats; the manifestation and clinical implication. Mol Cell Endocrinol 2003, 202:47-52.
• [34]Ussing HH, Zerahn K: Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Acta Physiol Scand 1951, 23:110-127.
• [35]Schwarzler P, Abendstein BJ, Klingler A, Kreuzer E, Rjosk HK: Prevention of severe ovarian hyper stimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression–a prospective randomized study. Human Fertil 2003, 6:125-129.
• [36]Preston GM, Jung JS, Guggino WB, Agre P: The mercury-sensitive residue at cysteine 189 in the CHIP28 water channel. J Biol Chem 1993, 268:17-20.